Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection
| Image |  |
|---|---|
| Description | scholarly article by Zobair M. Younossi published in July 2018 |
| Author/s |
author: Jia-Horng Kao Zobair M Younossi Young-Suk Lim Maria Stepanova |
| Publication date | July 4, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |